covid-19-sidebar Archives | Future Medicine India


Oxford’s COVID-19 vaccine prompts immune response among old as well as young adults

University of Oxford’s leading COVID-19 experimental vaccine produced similar immunogenicity responses in both old and young adults with lower adverse responses among the elderly, said the AstraZeneca Plc .

Read More..

Roxadustat improves CVD outcomes in anaemic patients with CKD

Roxadustat lowered the adverse cardiovascular events in chronic kidney disease (CKD) patients with anaemia, according to data recently presented at American Society of Nephrology (ASN) Kidney Week.


CDSCO approves phase III studies on indigenous Covaxin for COVID-19

Bharat Biotech has received approval from the Central Drugs Standard Control Organisation (CDSCO) for conducting phase III clinical trials of its COVID-19 vaccine- Covaxin.


US FDA grants approval to remdesivir for COVID-19 treatment

The US. FDA has recently approved the antiviral drug remdesivir (Veklury) for use in adult and paediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19 requiring hospitalisation.


US FDA okays phase 1 study of gamma delta T cell therapy for non-Hodgkin’s lymphoma

The FDA has recently approved the investigational new drug (IND) application for ADI-001, an allogeneic gamma delta (γδ) T cell therapy for the treatment of for B-cell non-Hodgkin’s lymphoma (NHL), announced the biotechnology company Adicet.


Oxford’s COVID-19 vaccine trial resumes in the U.S

The US FDA has authorised to resume the clinical trial of Oxford’s COVID-19 vaccine on Friday, according to AstraZeneca


Scientists discover new pair of salivary glands in human body

Researchers from the Netherlands Cancer Institute in Amsterdam, have recently identified what seems to be a previously overlooked set of salivary glands in the upper part of the throat. The discovery suggests the first set of new salivary glands in about 300 years.